Exelixis quarterly revenue rises 10.2% to $658.7 million
Exelixis' revenue growth is holding steady. Results for the quarter ended October 2, 2026, from the earnings release filed with the SEC on Oct 29, 2026.
Snapshot
Exelixis' revenue growth is holding steady: revenue rose 10.2% to $658.7 million in the quarter ended October 2, 2026, from $597.8 million a year earlier, after 10.6% year over year growth the quarter before.
- Independent Research
Market Data
| Company | 1D % | Price |
|---|---|---|
| ($EXEL) | ▲ +7.45% | 71.13 |
as of 10:02 ET · Realtime derived data
What We Know
Revenue for the quarter ended October 2, 2026 was $658.7 million, versus $597.8 million in the same quarter a year earlier, up 10.2%. That is its highest quarterly revenue of the last eight quarters. Diluted earnings per share was $0.85, up from $0.69.
Quarterly revenue by fiscal quarter end, oldest first: Jan 2025: $566.8 million; Apr 2025: $555.4 million; Jul 2025: $568.3 million; Oct 2025: $597.8 million; Jan 2026: $598.7 million; Apr 2026: $610.8 million; Jul 2026: $628.7 million; Oct 2026: $658.7 million.
Octans View
Year over year revenue change by quarter, computed from the filed figures: Jan 2026 up 5.6%; Apr 2026 up 10.0%; Jul 2026 up 10.6%; Oct 2026 up 10.2%. On those figures, Exelixis' revenue growth is holding steady. That read compares the latest two year over year growth rates and nothing else.
Bear Case · Room for Disagreement
This brief covers reported revenue and diluted earnings per share only. It does not cover guidance, margins, segment results, cash flow or the earnings call, and it makes no forecast. Revenue is the total on the release line we matched; a company's own adjusted measures can differ.
Method and source. Octans Research matched the revenue line in the earnings release (Exhibit 99.1) to the year ago quarter the company reported in its own XBRL financial data; the two must agree before anything is published. The quarterly history comes from the same XBRL data. The text is generated from those verified figures by a fixed template; no model wrote it.
Chart
Sources
- [1]SEC EDGAR — Exelixis earnings release for the quarter ended October 2, 2026 (Exhibit 99.1), filed Oct 29, 2026
- [2]SEC EDGAR — Exelixis XBRL financial data (company facts)
These are the sources this piece was drafted from. How we verify. Found an error? Tell us and we correct it in public.
$658.7M
More on $EXEL
4 reports
CNO Financial quarterly revenue falls 8.6% to $1.09 billion
CNO Financial has slipped into decline. Results for the quarter ended September 30, 2026, from the earnings release filed with the SEC on Oct 29, 2026.
Mohawk Industries quarterly revenue edges up 1.0% to $2.79 billion
Mohawk Industries' revenue growth has nearly stalled. Results for the quarter ended October 3, 2026, from the earnings release filed with the SEC on Oct 29, 2026.
Healthcare Realty Trust quarterly revenue falls 3.7% to $286.6 million
Healthcare Realty Trust's revenue is still shrinking, but more slowly. Results for the quarter ended September 30, 2026, from the earnings release filed with the SEC on Oct 29, 2026.
AGCO quarterly revenue falls 8.6% to $2.26 billion
AGCO's revenue decline is deepening. Results for the quarter ended September 30, 2026, from the earnings release filed with the SEC on Oct 29, 2026.